Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1488-2026

Olympus Single use Biopsy Valve. Recall

Olympus Single use Biopsy Valve. Model/Catalog Number: MAJ-210. 20 units per box. The MAJ-210 has been designed to be attached to the instrument channel port of compatible endoscopes to prevent reflux of body fluids.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Olympus Single use Biopsy Valve.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1488-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jan 29, 2026
FDA report date
Mar 11, 2026
Quantity in commerce
95,882 boxes (20 per box)
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Olympus Single use Biopsy Valve. Model/Catalog Number: MAJ-210. 20 units per box. The MAJ-210 has been designed to be attached to the instrument channel port of compatible endoscopes to prevent reflux of body fluids.

Affected model & UDI checker

Search the exact identifiers published for Z-1488-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
MAJ-210Olympus Single use Biopsy Valve.Check source noticeNot specified
Not specifiedOlympus Single use Biopsy Valve.Check source notice14953170152433
Not specifiedOlympus Single use Biopsy Valve.Check source notice14953170452069
FDA code information

Model/Catalog Number: MAJ-210. UDI-DI: 14953170152433, 14953170452069. All Lot Numbers. 20 units per box.

View the original FDA recall notice

Why was this product recalled?

Potential for rubber fragment detachment during use.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Olympus Corporation of the Americas take?

Olympus notified consignees on about 01/29/2026 via letter titled URGENT: FIELD SAFETY NOTICE. Consignees were instructed to carefully read the content of the notification, ensure all personnel are completely knowledgeable and thoroughly trained on the content of this notification, and that they may continue using the devices as per the notification and instructions for use. Olympus is highlighting the importance of strictly adhering to the Inspection of the Biopsy Valve and Inserting and Withdrawing the Endo-therapy accessories sections in the IFU related to the detachment of fragment from the slit part of rubber. Consignees were requested to acknowledge receipt of the notification via their portal and if product has been further distributed to notify those consignees.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology